Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
- Correlated keywords
- anti-inflammatory diaryl heterocycle inhibit COXs COX2 2 two cyclooxygenases cyclooxygenase-2 COX-2 antitumors anti-tumors antiinflammatory apoptosis selective therapeutic NSAID sulfonamide nonsteroidal YM 177 YMs 177 YM177 SC58635 SC 58635 SCs 58635 eurocox medicoxib apopeotsis non-steroidal Celebra Celebrex Onsenal Xilebao?
- Product Overview:
Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) and COX-2 inhibitor (IC50 = 0.05 µM).{11633} It is selective for COX-2 over COX-1 (IC50 = 22.9 µM).{11633,8926} Celecoxib induces apoptosis in BJAB and Jurkat cancer cells in a concentration-dependent manner.{12660} It reduces blood glucose levels in a rat model of diabetes induced by streptozotocin (STZ; Item No. 13104).{41722} Celecoxib reduces the latency to escape and the path length in the Morris water maze, as well as increases BDNF and tropomyosin-related kinase B (TrkB) protein levels in the hippocampus, in the same model. It inhibits the production of IL-1? and TNF-? and reduces synovial fluid expression of the gene encoding matrix metalloproteinase-3 (MMP-3) in a rabbit model of osteoarthritis when administered intra-articularly.{41721} Celecoxib (100 mg/kg per day) increases serum levels of lactate dehydrogenase (LDH), troponin-T, TNF-?, and creatine kinase-MB (CK-MB), markers of cardiotoxicity, in rats.{69167} Formulations containing celecoxib have been used in the treatment of osteoarthritis, and rheumatoid arthritis, and as an analgesic.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.